Development of novel nitric oxide production inhibitors based on the 7H-pyrrolo[2,3-d]pyrimidine scaffold
Molecular Diversity · 2025
DOI: 10.1007/s11030-024-10866-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Jie Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical College, Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation, Guangxi Medical University, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Nitric Oxide, Pyrimidines, Anti-Inflammatory Agents, Pyrroles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Natural Science Foundation of Guangxi, National Natural Science Foundation of China.
Abstract (Originalsprache)
Nitric oxide (NO), the smallest signaling molecule known, can be excessively produced by overexpressed inducible nitric oxide synthase (iNOS), and eventually leads to multiple inflammatory related diseases. Thus, reducing the overexpression of NO represents as very potential anti-inflammatory strategy. In current study, a series of compounds were designed and synthesized based on the hybridization of 7H-pyrrolo[2,3-d]pyrimidine and cinnamamide fragments in order to develop novel NO production inhibitors. Among them, compound S2h displayed a vigorous inhibitory activity on NO production with an IC50 value of 3.21 ± 0.67 µM, which was much lower than that of the positive control Nω-nitro-L-arginine (L-NNA, IC50 = 28.36 ± 3.13 µM). Due to its obeying Lipinski's and Veber's rules that guarantee compounds with good oral bioavailability, S2h effectively suppressed the paw swelling in carrageenan-induced mice. Additionally, compound S2h formed clear interactions with iNOS protein according to the docking analysis. Therefore, compounds S2h is a promising lead compound for further development of potent iNOS inhibitors or anti-inflammatory agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical College, Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation, Guangxi Medical University, Nanning, Guangxi, China.
- College of Basic Medical Science, Key Laboratory of Basic Research on Regional Diseases, Guangxi Medical University, Guangxi, China.
- College of Basic Medical Science, Key Laboratory of Basic Research on Regional Diseases, Guangxi Medical University, Guangxi, China. yue2830827@hotmail.com.
- Pharmaceutical College, Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation, Guangxi Medical University, Nanning, Guangxi, China. HLhongedu@163.com.
Förderung
- Natural Science Foundation of Guangxi
- National Natural Science Foundation of China
Zitieren
APA
Zhang, J., Xie, X., Qin, T., Yao, H., Ling, Z., Deng, F., Yue, X., & He, L. (2025). Development of novel nitric oxide production inhibitors based on the 7H-pyrrolo[2,3-d]pyrimidine scaffold. Molecular Diversity. https://doi.org/10.1007/s11030-024-10866-0
Vancouver
Zhang J, Xie X, Qin T, Yao H, Ling Z, Deng F, et al. Development of novel nitric oxide production inhibitors based on the 7H-pyrrolo[2,3-d]pyrimidine scaffold. Molecular Diversity. 2025. doi:10.1007/s11030-024-10866-0
BibTeX
@article{Zhang2025,
author = {Zhang, Jie and Xie, Xin and Qin, Tingsheng and Yao, Hualiang and Ling, Zhen and Deng, Fengyuan and Yue, Xiaoyang and He, Linhong},
title = {Development of novel nitric oxide production inhibitors based on the 7H-pyrrolo[2,3-d]pyrimidine scaffold},
journal = {Molecular Diversity},
year = {2025},
doi = {10.1007/s11030-024-10866-0}
}
EUVIMED